SCHEMBL4171364

SCHEMBL4171364

O=C(C#Cc1ccc(Cl)cc1Cl)NCCc1cccc(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.53
ALDH1A1 P00352 6/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.52
HPGD P15428 1/20 0.52
TAAR1 Q96RJ0 2/20 0.50
PLAAT3 P53816 2/20 0.49
PLAAT5 Q96KN8 2/20 0.49
PLAAT2 Q9NWW9 2/20 0.49
PLAAT4 Q9UL19 2/20 0.49
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
HTT P42858 1/20 0.48
GAA P10253 1/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
THRB P10828 1/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4168072 0.88 PYGL (0.50) CNR1KMT2AMEN1PLAAT3PLAAT5
SCHEMBL4180632 0.84 CNR1 (0.50) CNR1ALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL4171418 0.84 CNR1 (0.50) CNR1ALDH1A1KMT2AMEN1HPGD
SCHEMBL4182119 0.83 ALDH1A1 (0.48) CNR1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL4179866 0.83 ALDH1A1 (0.56) CNR1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL4186329 0.83 ALDH1A1 (0.53) CNR1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL4174123 0.83 ALDH1A1 (0.53) CNR1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL4181881 0.82 ALDH1A1 (0.54) CNR1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL4173101 0.82 ALDH1A1 (0.61) CNR1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL4177479 0.82 SMN1; SMN2 (0.49) CNR1ALDH1A1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090182020-A1 SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS GRUNENTHAL GMBH (DE) 2009-07-16 US claimed
EP-1968935-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2008-09-17 EP claimed
WO-2007079958-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2007-07-19 WO claimed
US-20090182020-A1 SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS GRUNENTHAL GMBH (DE) 2009-07-16 US disclosed
EP-1968935-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079958-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182020-A1 SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS FHIT, CYP3A43, DNPEP CNR1 396/4885ALDH1A1 2932/4885SMN1; SMN2 4869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.